Stay updated on Clinical Trial: Nivolumab in HCC with Electroporation
Sign up to get notified when there's something new on the Clinical Trial: Nivolumab in HCC with Electroporation page.

Latest updates to the Clinical Trial: Nivolumab in HCC with Electroporation page
- Check4 days agoChange DetectedRemoval of a PubMed citation for the NIVOLEP trial from the Publications section. The note indicating that publications are auto-filled from PubMed was also removed.SummaryDifference0.2%

- Check11 days agoChange DetectedThe page’s revision tag was updated from v3.5.2 to v3.5.3, signaling a new administrative update to the ClinicalTrials.gov record. This is a metadata change rather than a substantive modification to the study information.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded a PubMed-listed publication citation for the NIVOLEP trial and a 'From PubMed' note. Included a revision tag: Revision: v3.5.2.SummaryDifference0.2%

- Check54 days agoChange DetectedAdded Hepatocellular Carcinoma as the study condition and a Resources link to Genetic and Rare Diseases Information Center. Updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check61 days agoChange DetectedRevision log updated to include v3.4.3 and remove v3.4.2.SummaryDifference0.1%

- Check90 days agoChange DetectedSite-wide revision updates were applied (Revision: v3.4.2) with removal of the prior funding/operating status notice (Revision: v3.4.1), which does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Clinical Trial: Nivolumab in HCC with Electroporation
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Nivolumab in HCC with Electroporation page.